BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 22
• 23
• 24
• 25
• 28

• Drug Development

  Dynavax Technologies Corporation’s Two Phase 3 HEPLISAV Trials Cleared by DSMB to Continue to Study Completion

  February 23, 2011

   · 

  3 min read
• Business

  BIOLASE Technology, Inc. Announces Unaudited Fourth Quarter Net Income of $0.01 per Share and Non-GAAP Net Income of $0.03 per Share

  February 23, 2011

   · 

  5 min read
• Business

  Cell Signaling Technology, Inc. Announces Joint Commercialization Partnership with Astellas Pharma Inc. in Cancer Personalized Medicine

  February 23, 2011

   · 

  1 min read
• Business

  INC Research, Inc. Continues to Grow Alliance Partnership Team With Bruce Wakeman

  February 23, 2011

   · 

  2 min read
• Bio NC

  Salix Pharmaceuticals, Ltd. to Present at Three Investment Conferences in March

  February 23, 2011

   · 

  1 min read
• FDA

  Prometheus Laboratories Inc. Receives New York State Approval for PROMETHEUS(R) Crohn’s Prognostic, the First Serogenetic Test to Predict Risk of Complications From Crohn’s Disease

  February 23, 2011

   · 

  2 min read
• BioMidwest

  Stereotaxis, Inc. Announces First Worldwide Use of Remote Magnetic Navigation for Renal Ablation to Treat Hypertension

  February 23, 2011

   · 

  5 min read
• Pharm Country

  Johnson & Johnson to Participate in 2011 RBC Capital Markets’ Health Care Conference

  February 23, 2011

   · 

  1 min read
• Genetown

  Momenta Pharmaceuticals, Inc. Announces Webcast of Presentations at Upcoming Investment Conferences

  February 23, 2011

   · 

  1 min read
• AEterna Zentaris Announces “At-the-Market” Issuance Program

  February 23, 2011

   · 

  2 min read